# MAOA

## Overview
The MAOA gene encodes the enzyme monoamine oxidase A, a critical component in the catabolism of monoamines, such as serotonin, norepinephrine, and dopamine. This enzyme is categorized as a membrane-associated protein, specifically located on the outer mitochondrial membrane, where it facilitates the oxidative deamination of neurotransmitters, thereby regulating their levels in the central nervous system and peripheral tissues (Denney1999Association; Shih1999MONOAMINE). The MAOA gene is situated on the X chromosome and exhibits genetic polymorphisms that can influence its expression and enzymatic activity, contributing to individual differences in mood and behavior (Balciuniene2001Investigation; Stabellini2009MAOA). Variations in MAOA activity have been implicated in several neuropsychiatric disorders, including Brunner syndrome and autism spectrum disorder, highlighting its clinical significance (Piton201320; Bortolato2018From). Additionally, MAOA's interactions with other proteins, such as NDRG1 and the androgen receptor, underscore its role in modulating key cellular pathways, with potential implications for cancer treatment (Wang2023MAOA; Wei2021Bidirectional).

## Structure
The human monoamine oxidase A (MAOA) protein is a membrane-associated enzyme located on the outer mitochondrial membrane. Its molecular structure has been elucidated through X-ray crystallography, revealing a resolution of 2.2 Å (Edmondson2009Molecular; Son2008Structure). The primary structure of MAOA includes a sequence of amino acids that form specific domains, such as the FAD-binding domain, substrate-binding domain, and membrane-binding domain (Ma2004Structure). The secondary structure is characterized by alpha helices and beta sheets, with a notable transmembrane α-helix formed by the C-terminal residues (Edmondson2009Molecular).

The tertiary structure of MAOA is globular, incorporating a covalently bound flavin adenine dinucleotide (FAD) cofactor, which is crucial for its enzymatic activity (Ma2004Structure). The quaternary structure of human MAOA is monomeric in its crystallized form, unlike the dimeric structures observed in rat MAOA and human MAOB (Son2008Structure). The enzyme's active site features a compact cavity, which influences substrate and inhibitor specificity (Edmondson2009Molecular). Post-translational modifications, such as phosphorylation, are common in MAOA, affecting its function and regulation. The structural insights into MAOA are essential for understanding its role in neurotransmitter degradation and for developing therapeutic agents targeting psychiatric disorders (Son2008Structure).

## Function
Monoamine oxidase A (MAOA) is an enzyme located on the outer mitochondrial membrane, where it plays a crucial role in the oxidative deamination of monoamines, including serotonin, norepinephrine, and dopamine. This enzymatic activity is essential for regulating neurotransmitter levels in the brain and peripheral tissues, thereby influencing mood and behavior (Denney1999Association; Shih1999MONOAMINE). MAOA preferentially oxidizes serotonin and norepinephrine, and its activity is inhibited by clorgyline (Zhu1992Promoter).

The MAOA gene is located on the X chromosome and is subject to X chromosome inactivation in human fibroblasts, which affects its expression (Stabellini2009MAOA). The enzyme's activity can vary significantly between individuals due to genetic polymorphisms, such as the variable number tandem repeat (VNTR) in the MAOA promoter, which influences transcriptional activity and, consequently, enzyme levels (Denney1999Association; Balciuniene2001Investigation).

MAOA's function in healthy human cells is vital for maintaining neurotransmitter balance, which is crucial for emotional and cognitive functions. Variations in MAOA activity have been linked to differences in mood and behavior, highlighting its importance in neuropsychiatric conditions (Shumay2012Evidence).

## Clinical Significance
Mutations and altered expression of the MAOA gene are linked to several neuropsychiatric disorders. Brunner syndrome, a condition characterized by impulsive aggression and mild cognitive impairments, is associated with a point mutation in exon 8 of the MAOA gene, leading to a congenital deficiency of the enzyme (Brunner1993Abnormal; Bortolato2018From). This deficiency results in altered neurotransmitter metabolism, including increased serotonin levels and decreased serotonin metabolite 5-HIAA, which are linked to aggressive behavior (Brunner1993Abnormal; Cases1995Aggressive).

MAOA mutations have also been implicated in autism spectrum disorder (ASD) and intellectual disability. A specific missense mutation, c.797_798delinsTT (p.C266F), has been identified in individuals with ASD, attention deficit, and aggressive behavior, leading to reduced MAOA activity (Piton201320). This mutation affects a highly conserved residue near the FAD-binding pocket, impacting enzymatic activity and contributing to neurodevelopmental and behavioral issues (Piton201320).

Low-activity alleles of MAOA, such as the 3-repeat variant in the promoter region, are associated with increased risk of antisocial behavior and aggression, particularly in individuals with a history of childhood maltreatment (Piton201320; Bortolato2018From). These genetic variations can lead to morphological and functional brain abnormalities, predisposing individuals to reactive aggression (Bortolato2018From).

## Interactions
Monoamine oxidase A (MAOA) participates in several interactions with other proteins that influence its function and role in various cellular processes. In gastric cancer, MAOA interacts with NDRG1, a tumor suppressor, to regulate the Warburg effect through the PI3K/AKT/mTOR pathway. This interaction is significant in suppressing cancer cell growth and metabolism, as MAOA overexpression leads to decreased phosphorylation of PI3K, AKT, and mTOR, thereby inhibiting glycolysis and promoting tumor-suppressing pathways (Wang2023MAOA).

In prostate cancer, MAOA is involved in a bidirectional cross-talk with the androgen receptor (AR). MAOA expression is positively correlated with AR target genes, and AR can regulate MAOA expression at the transcriptional level. This interaction enhances AR transcriptional activity and is mediated through the Shh/Gli-YAP1 signaling pathway. MAOA promotes AR activity by facilitating the interaction between nuclear YAP1 and AR, which is crucial for AR transactivation. Silencing MAOA reduces AR-mediated prostate cancer development, suggesting that MAOA supports AR function and contributes to prostate cancer progression (Wei2021Bidirectional).

These interactions highlight the role of MAOA in modulating key signaling pathways and its potential as a therapeutic target in cancer treatment.


## References


[1. (Brunner1993Abnormal) H. G. Brunner, M. Nelen, X. O. Breakefield, H. H. Ropers, and B. A. van Oost. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase a. Science, 262(5133):578–580, October 1993. URL: http://dx.doi.org/10.1126/science.8211186, doi:10.1126/science.8211186. This article has 1139 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.8211186)

[2. (Cases1995Aggressive) Olivier Cases, Isabelle Seif, Joseph Grimsby, Patricia Gaspar, Kevin Chen, Sandrine Pournin, Ulrike Müller, Michel Aguet, Charles Babinet, Jean Chen Shih, and Edward De Maeyer. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking maoa. Science, 268(5218):1763–1766, June 1995. URL: http://dx.doi.org/10.1126/science.7792602, doi:10.1126/science.7792602. This article has 921 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.7792602)

[3. (Balciuniene2001Investigation) J. Balciuniene, L. Emilsson, L. Oreland, U. Pettersson, and E. Jazin. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Human Genetics, 110(1):1–7, December 2001. URL: http://dx.doi.org/10.1007/s00439-001-0652-8, doi:10.1007/s00439-001-0652-8. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-001-0652-8)

[4. (Shih1999MONOAMINE) J. C. Shih, K. Chen, and M. J. Ridd. Monoamine oxidase: from genes to behavior. Annual Review of Neuroscience, 22(1):197–217, March 1999. URL: http://dx.doi.org/10.1146/annurev.neuro.22.1.197, doi:10.1146/annurev.neuro.22.1.197. This article has 945 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev.neuro.22.1.197)

[5. (Denney1999Association) R.M. Denney, H. Koch, and I.W. Craig. Association between monoamine oxidase a activity in human male skin fibroblasts and genotype of the maoa promoter-associated variable number tandem repeat. Human Genetics, 105(6):542–551, November 1999. URL: http://dx.doi.org/10.1007/s004399900183, doi:10.1007/s004399900183. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004399900183)

[6. (Shumay2012Evidence) Elena Shumay, Jean Logan, Nora D. Volkow, and Joanna S. Fowler. Evidence that the methylation state of the monoamine oxidase a (maoa) gene predicts brain activity of mao a enzyme in healthy men. Epigenetics, 7(10):1151–1160, October 2012. URL: http://dx.doi.org/10.4161/epi.21976, doi:10.4161/epi.21976. This article has 103 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/epi.21976)

[7. (Ma2004Structure) Jichun Ma, Masato Yoshimura, Eiki Yamashita, Atsushi Nakagawa, Akio Ito, and Tomitake Tsukihara. Structure of rat monoamine oxidase a and its specific recognitions for substrates and inhibitors. Journal of Molecular Biology, 338(1):103–114, April 2004. URL: http://dx.doi.org/10.1016/J.JMB.2004.02.032, doi:10.1016/j.jmb.2004.02.032. This article has 247 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/J.JMB.2004.02.032)

[8. (Stabellini2009MAOA) Raquel Stabellini, Joana Carvalho Moreira de Mello, Lys Molina Hernandes, and Lygia V. Pereira. Maoa and gyg2 are submitted to x chromosome inactivation in human fibroblasts. Epigenetics, 4(6):388–393, August 2009. URL: http://dx.doi.org/10.4161/epi.4.6.9492, doi:10.4161/epi.4.6.9492. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/epi.4.6.9492)

[9. (Son2008Structure) Se-Young Son, Jichun Ma, Youhei Kondou, Masato Yoshimura, Eiki Yamashita, and Tomitake Tsukihara. Structure of human monoamine oxidase a at 2.2-å resolution: the control of opening the entry for substrates/inhibitors. Proceedings of the National Academy of Sciences, 105(15):5739–5744, April 2008. URL: http://dx.doi.org/10.1073/pnas.0710626105, doi:10.1073/pnas.0710626105. This article has 482 citations.](https://doi.org/10.1073/pnas.0710626105)

[10. (Zhu1992Promoter) QS Zhu, J Grimsby, K Chen, and JC Shih. Promoter organization and activity of human monoamine oxidase (mao) a and b genes. The Journal of Neuroscience, 12(11):4437–4446, November 1992. URL: http://dx.doi.org/10.1523/jneurosci.12-11-04437.1992, doi:10.1523/jneurosci.12-11-04437.1992. This article has 97 citations.](https://doi.org/10.1523/jneurosci.12-11-04437.1992)

[11. (Piton201320) Amélie Piton, Hélène Poquet, Claire Redin, Alice Masurel, Julia Lauer, Jean Muller, Julien Thevenon, Yvan Herenger, Sophie Chancenotte, Marlène Bonnet, Jean-Michel Pinoit, Frédéric Huet, Christel Thauvin-Robinet, Anne-Sophie Jaeger, Stéphanie Le Gras, Bernard Jost, Bénédicte Gérard, Katell Peoc’h, Jean-Marie Launay, Laurence Faivre, and Jean-Louis Mandel. 20 ans après: a second mutation in maoa identified by targeted high-throughput sequencing in a family with altered behavior and cognition. European Journal of Human Genetics, 22(6):776–783, October 2013. URL: http://dx.doi.org/10.1038/ejhg.2013.243, doi:10.1038/ejhg.2013.243. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2013.243)

[12. (Wang2023MAOA) Yang-Yang Wang, Yao-Qi Zhou, Jia-Xuan Xie, Xiang Zhang, Shu-Chang Wang, Qing Li, Li-Peng Hu, Shu-Heng Jiang, Shuang-Qin Yi, Jia Xu, Hui Cao, En-Hao Zhao, and Jun Li. Maoa suppresses the growth of gastric cancer by interacting with ndrg1 and regulating the warburg effect through the pi3k/akt/mtor pathway. Cellular Oncology, 46(5):1429–1444, May 2023. URL: http://dx.doi.org/10.1007/s13402-023-00821-w, doi:10.1007/s13402-023-00821-w. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13402-023-00821-w)

[13. (Edmondson2009Molecular) Dale E. Edmondson, Claudia Binda, Jin Wang, Anup K. Upadhyay, and Andrea Mattevi. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry, 48(20):4220–4230, May 2009. URL: http://dx.doi.org/10.1021/bi900413g, doi:10.1021/bi900413g. This article has 248 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi900413g)

[14. (Bortolato2018From) Marco Bortolato, Gabriele Floris, and Jean C. Shih. From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency. Journal of Neural Transmission, 125(11):1589–1599, May 2018. URL: http://dx.doi.org/10.1007/s00702-018-1888-y, doi:10.1007/s00702-018-1888-y. This article has 48 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00702-018-1888-y)

[15. (Wei2021Bidirectional) Jing Wei, Lijuan Yin, Jingjing Li, Jing Wang, Tianjie Pu, Peng Duan, Tzu-Ping Lin, Allen C. Gao, and Boyang Jason Wu. Bidirectional cross-talk between maoa and ar promotes hormone-dependent and castration-resistant prostate cancer. Cancer Research, 81(16):4275–4289, June 2021. URL: http://dx.doi.org/10.1158/0008-5472.CAN-21-0198, doi:10.1158/0008-5472.can-21-0198. This article has 11 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.CAN-21-0198)